Predicting outcomes for acute pancreatitis patients
Part of Digestive system clinical trials.
This study looks at people with sudden pancreas inflammation (acute pancreatitis) to see if certain factors can predict how well they recover. It may help doctors better understand your condition and plan your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have belly pain that matches acute pancreatitis symptoms.
- Your blood test shows high amylase (an enzyme from the pancreas) at least 3 times above normal.
- An ultrasound or CT scan shows signs of pancreatitis.
- You do not have liver disease, kidney disease, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how “inflammation” in the pancreas changes over time—going from a first or repeated attack to long-term (chronic) pancreatitis. It may help doctors understand what drives progression and identify people at higher risk for chronic disease.
This study follows people with chronic pancreatitis to learn more about the disease and how to better diagnose it. You may have research-related scans or procedures and will be asked to stay in follow-up over time.
This study observes adults with acute pancreatitis to learn more about how the condition presents and what happens to patients over time. By participating, you can help researchers improve care for this painful condition.
This trial looks at whether routine blood test results can help doctors predict how severe acute pancreatitis will be and how well patients may recover. It aims to find simple, early clues to guide treatment.
This study looks at why some people develop diabetes after acute pancreatitis and how that process works in the body. It may help doctors better predict risk and tailor care for people recovering from pancreatitis.
This study looks at how the bacteria in your gut (microbiome) might affect the severity of a first-time acute pancreatitis attack. It aims to see if certain gut bacteria can predict how serious the illness will be, which could help doctors treat patients better.
Hear when a new Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.